pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
JMKX-1899
Colorectal Cancer
HUYA Bioscience International LLC
0
catalysts
Phase 3
JNJ-1900
Head And Neck Squamous Cell Carcinoma (HNSC)
$JNJ
JOHNSON & JOHNSON
0
catalysts
Phase 2
JNJ-2056
Alzheimer's Disease
Johnson & Johnson Innovative Medicine
0
catalysts
Phase 3
← prev
page 99 of 231
next →
131
Pain
89
Neurology
1
JNJ-69968054
Escherichia coli Infections
$JNJ
JOHNSON & JOHNSON
0
catalysts
Phase 2
JNS-101
Friedreich Ataxia
$JUNS
JUPITER NEUROSCIENCES, INC.
0
catalysts
Phase 1
JNS-107
MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-L…
$JUNS
JUPITER NEUROSCIENCES, INC.
0
catalysts
Preclinical
JNS-108
Mild Cognitive Impairment
$JUNS
JUPITER NEUROSCIENCES, INC.
0
catalysts
Phase 1
JNS-115
Parkinson's Disease
$JUNS
JUPITER NEUROSCIENCES, INC.
0
catalysts
JOYEAUX
JOYEAUX (LEVONORGESTREL AND ETHINYL ESTRADIOL AND FERROUS FUMARATE)
XIROMED
0
catalysts
Phase 1
JPH-034
Glioma
J-Pharma Co Ltd
0
catalysts
Preclinical
JR-220
Alcohol Use Disorder (AUD)
Naprogenix Inc
0
catalysts
Preclinical
JV-MD2 (Omega-3)
Retinopathy Of Prematurity
Jenivision Inc (Inactive)
0
catalysts
Phase 2
JWATM-204
Hepatocellular Carcinoma
Eureka Therapeutics Inc
0
catalysts
Phase 1
JZP-3507
Ependymoma
$JAZZ
Jazz Pharmaceuticals plc
0
catalysts
Phase 1
JZP-898
Gastroesophageal (GE) Junction Carcinomas
$JAZZ
Jazz Pharmaceuticals plc
0
catalysts
Phase 2
JadiCell ARDS
Acute Respiratory Distress Syndrome
Breathe Biologics Inc
0
catalysts
Phase 2
Jankistomig
Solid Tumor
Ottimo Pharma Ltd
0
catalysts
Phase 3
JointStem
Osteoarthritis
Biostar Stem Cell Research Institute
0
catalysts
Phase 3
Jynneos
Smallpox
Bavarian Nordic AS
0
catalysts
Preclinical
K-130
Neurogenic Orthostatic Hypotension (nOH)
$AMRX
Amneal Pharmaceuticals, Inc.
0
catalysts
Phase 3
K-161
Keratoconjunctivitis Sicca (Dry Eye)
Kowa Co Ltd
0
catalysts
Phase 1
KA-34
Osteoarthritis
California Institute for Biomedical Research
0
catalysts
KANJINTI
KANJINTI (TRASTUZUMAB-ANNS)
$AMGN
AMGEN INC
0
catalysts
Phase 1
KB-407
Cystic Fibrosis
$KRYS
Krystal Biotech, Inc.
0
catalysts
Phase 1
KB-408
Alpha-1 Antitrypsin Deficiency (A1AD)
$KRYS
Krystal Biotech, Inc.
0
catalysts
Phase 2
KB-707
Metastatic Melanoma
$KRYS
Krystal Biotech, Inc.
0
catalysts
Phase 2
KB-801
Neurotrophic Keratitis
$KRYS
Krystal Biotech, Inc.
0
catalysts
Phase 2
KBLP-001
Plaque Psoriasis (Psoriasis Vulgaris)
KoBioLabs Inc
0
catalysts
Phase 1
KBLP-002
Asthma
KoBioLabs Inc
0
catalysts
Preclinical
KBX-114
Gynecological Cancer
Kaida BioPharma Inc
0
catalysts
